Form 8-K - Current report:
SEC Accession No. 0000886163-15-000056
Filing Date
2015-05-05
Accepted
2015-05-05 08:14:21
Documents
3
Period of Report
2015-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K-VIKINGIPO lgndform8-kxclosingvikingi.htm 8-K 31524
2 EXHIBIT 99.1VIKINGPRESSRELEASE lgnd_vktxipox5415.htm EX-99.1 14413
3 lgndvktxipo5415image1.gif GRAPHIC 11576
  Complete submission text file 0000886163-15-000056.txt   63155
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 15830511
SIC: 2834 Pharmaceutical Preparations